Details for Patent: 8,450,338

Which drugs does patent 8,450,338 protect, and when does it expire?

Patent 8,450,338 protects PREPOPIK and is included in one NDA.

This patent has thirty-two patent family members in twenty-five countries.

Summary for Patent: 8,450,338

Title:	Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof
Abstract:	Compositions are provided that are useful for the preparation of a medicament. The compositions comprise granules having a layer of sodium picosulphate coated on potassium bicarbonate. Additional granules having a layer of magnesium oxide coated on a core of citric acid are also provided. The two types of granules may be combined to obtain mixtures (preferably homogeneous or substantially homogeneous mixtures) of the two types of granules, which are useful, e.g., as pharmaceutical compositions.
Inventor(s):	Xu; Haijun (Zhongshan, CN), Diao; Tiejun (Zhongshan, CN)
Assignee:	Ferring International Center S.A. (St-Prex, CH)
Application Number:	13/246,739
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,450,338
Patent Claim Types: see list of patent claims	Composition; Formulation; Process;

Drugs Protected by US Patent 8,450,338

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ferring Pharms Inc	PREPOPIK	citric acid; magnesium oxide; sodium picosulfate	FOR SOLUTION;ORAL	202535-001	Jul 16, 2012		DISCN	Yes	No			Y

Foreign Priority and PCT Information for Patent: 8,450,338

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	07254049	Oct 12, 2007
China	2007 1 0186023	Nov 09, 2007
United Kingdom	0805953.7	Apr 01, 2008

International Family Members for US Patent 8,450,338

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2008309287
Brazil	PI0818541
Canada	2702152
China	101406457